PRFX
NASDAQ · Pharmaceuticals
Prf Technologies Ltd
$1.04
-0.06 (-5.45%)
Open$1.09
Previous Close$1.10
Day High$1.12
Day Low$1.03
52W High$17.95
52W Low$0.97
Volume—
Avg Volume190.4K
Market Cap3.16M
P/E Ratio—
EPS$-12.92
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,050.0% upside
Current
$1.04
$1.04
Target
$11.96
$11.96
$8.59
$11.96 avg
$16.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 75.3K | 3.33M | 3.45M |
| Net Income | -21,472,707 | 722.6K | 805.0K |
| Profit Margin | -28,458.8% | 21.7% | 23.3% |
| EBITDA | -19,364,377 | 1.33M | 1.25M |
| Free Cash Flow | — | 449.2K | 396.5K |
| Rev Growth | — | -7.5% | +9.4% |
| Debt/Equity | — | 0.57 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |